Home > Insider Trading > Filing (0001209191-15-065547)

Filing Details

Accession Number:: 0001209191-15-065547
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-08-12 16:02:48
Reporting Period:: 2015-08-10

Filing Date:: 2015-08-12
Accepted Time:: 2015-08-12 16:02:48
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1293971	Bluebird Bio Inc.	BLUE	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1595896	James Mandell	C/O Bluebird Bio, Inc. 150 Second Street Cambridge MA 02141		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-08-10	1,500	$21.43	1,500	No	4	M	Direct
Common Stock	Disposition	2015-08-10	626	$146.83	874	No	4	S	Direct
Common Stock	Disposition	2015-08-10	299	$147.88	575	No	4	S	Direct
Common Stock	Disposition	2015-08-10	194	$148.75	381	No	4	S	Direct
Common Stock	Disposition	2015-08-10	164	$150.28	217	No	4	S	Direct
Common Stock	Disposition	2015-08-10	127	$151.71	90	No	4	S	Direct
Common Stock	Disposition	2015-08-10	90	$152.86	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2015-08-10	1,500	$0.00	1,500	$21.43

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
18,500		2024-01-08	No	4	M	Direct

Footnotes

This sales reported in the Form 4 were effectd pursuant to a 10b5-1 trading plan adopted by the reporting person on July 8, 2015.
The range in prices for the transaction reported on this line was $146.34 to 147.31. The average weighted price was $146.8308. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The range in prices for the transaction reported on this line was $147.45 to $148.25. The average weighted price was $147.8835. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The range in prices for the transaction reported on this line was $148.66 to $149.49. The average weighted price was $148.7503. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The range in prices for the transaction reported on this line was $149.81 to $150.81. The average weighted price was $150.2816. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The range in prices for the transaction reported on this line was $151.38 to $152.36. The average weighted price was $151.7102. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The range in prices for the transaction reported on this line was $152.61 to $153.00. The average weighted price was $152.8644. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
This option vests ratably over three years in annual installments, commencing on January 8, 2014.